PIK3CA

Open Access
Development of Acquired Resistance in Alpelisib-treated Gastric Cancer Cells With PIK3CA Mutations and Overcoming Strategies
MINSU KANG, KUI-JIN KIM, JI HEA SUNG, MILANG NAM, SUNG-HYUN HWANG, WOOCHAN PARK, JEONGMIN SEO, EUN HEE JUNG, KOUNG JIN SUH, JI-WON KIM, SE HYUN KIM, JIN WON KIM, YU JUNG KIM, JEE HYUN KIM and KEUN-WOOK LEE

Anticancer Research May 2025, 45 (5) 1877-1896; DOI: https://doi.org/10.21873/anticanres.17567
You have access
Clinicopathological and Molecular Insights into Primary Retroperitoneal Squamous Cell Carcinoma: HPV Association and Discovery of Recurrent PIK3CA E545K Mutation
HAN GYEOL KIM, SUNG KYOUNG MOON, HYUN-SOO KIM and KIYONG NA

Anticancer Research February 2025, 45 (2) 719-731; DOI: https://doi.org/10.21873/anticanres.17460
Open Access
PIK3CA Hotspot Mutations in Saliva as a Diagnostic Marker in Oral Squamous Cell Carcinoma Patients
KONSTANTIN KRÜGER, AUDREY GRUST, DAVID MUALLAH, ADRIAN PATENGE, HARRIET WIKMAN, MARIA MEDINA MESA, EIKE SÖREN KNUST, ALEXANDER SARTORI, RALF SMEETS, LAN KLUWE, REINHARD E. FRIEDRICH and SIMON BURG

Anticancer Research June 2024, 44 (6) 2369-2376; DOI: https://doi.org/10.21873/anticanres.17044
You have access
PIK3CA Mutations as a Prognostic Factor in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy
JUNGSUP BYUN, NORA JEE-YOUNG PARK, GHILSUK YOON, MIN KYU KANG, HYE JIN KIM, SOO YEUN PARK, JUN SEOK PARK, GYU SEOG CHOI, JIN HO BAEK, JONG GWANG KIM and AN NA SEO

Anticancer Research April 2023, 43 (4) 1513-1520; DOI: https://doi.org/10.21873/anticanres.16300
You have access
Predictive Role of TP53, PIK3CA and MLL2 in ER+ HER2+ Breast Bancer: Biomarker Analysis of Neo-ALL-IN [NCT 01275859]
JI HYUN PARK, JIN-HEE AHN, JEONG EUN KIM, KYUNG HAE JUNG, GYUNGYUB GONG, HEE JIN LEE, BYUNG-HO SON, SEI-HYUN AHN, HAK-HEE KIM, HEE JUNG SHIN, DAE-HYUK MOON, DEOKHOON KIM and SUNG-BAE KIM

Anticancer Research October 2020, 40 (10) 5883-5893; DOI: https://doi.org/10.21873/anticanres.14608
You have access
Exon 9 Mutation of PIK3CA Associated With Poor Survival in Patients With Epstein-Barr Virus-associated Gastric Cancer
AN NA SEO, BYUNG WOOG KANG, HAN IK BAE, OH KYOUNG KWON, KI BUM PARK, SEUNG SOO LEE, HO YOUNG CHUNG, WANSIK YU, SEONG WOO JEON, HYOJEUNG KANG and JONG GWANG KIM

Anticancer Research April 2019, 39 (4) 2145-2154; DOI: https://doi.org/10.21873/anticanres.13328
You have access
3D Culture Represents Apoptosis Induced by Trastuzumab Better than 2D Monolayer Culture
TAKASHI TATARA, TORU MUKOHARA, RINA TANAKA, YOHEI SHIMONO, YOHEI FUNAKOSHI, YOSHINORI IMAMURA, MASANORI TOYODA, NAOMI KIYOTA, MIDORI HIRAI, YOSHIHIRO KAKEJI and HIRONOBU MINAMI

Anticancer Research May 2018, 38 (5) 2831-2839;
You have access
Genomic Characterisation and Response to Trastuzumab and Paclitaxel in Advanced or Recurrent HER2-positive Endometrial Carcinoma
MARTIN KOSKAS, JEROEN DEPREEUW, STIJN MOENS, DANIELA ANNIBALI, TINE CUPPENS, PHILIPPE MOERMAN, DIETHER LAMBRECHTS and FREDERIC AMANT

Anticancer Research October 2016, 36 (10) 5381-5384;
You have access
In Vitro Anticancer Activity of PI3K Alpha Selective Inhibitor BYL719 in Head and Neck Cancer
BHUMSUK KEAM, SOYEON KIM, YONG-OON AHN, TAE MIN KIM, SE-HOON LEE, DONG-WAN KIM and DAE SEOG HEO

Anticancer Research January 2015, 35 (1) 175-182;
You have access
Gene Mutations in Squamous Cell NSCLC: Insignificance of EGFR, KRAS and PIK3CA Mutations in Prediction of EGFR-TKI Treatment Efficacy
ONDREJ FIALA, MILOS PESEK, JINDRICH FINEK, LUCIE BENESOVA, ZBYNEK BORTLICEK and MAREK MINARIK

Anticancer Research April 2013, 33 (4) 1705-1711;

Main menu

User menu

Search

PIK3CA

Pages